Clinical trial
Lapatinib and Bevacizumab for Metastatic Breast Cancer
NCT00444535
Study timeline
Study start (actual)2007-02-27Date precision: day
Registry last updated2021-10-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Neoplasms, Breastunresolved
Interventions
lapatinibDRUG · verified · RxNorm: lapatinib
bevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00444535 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.